Cirrhotic Cardiomyopathy: Isn't Stress Evaluation Always Required for the Diagnosis?

Overview

Journal World J Hepatol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2016 Feb 4

PMID 26839643

Citations 8

Authors

Mara Barbosa

Joana Guardado

Carla Marinho

Bruno Rosa

Isabel Quelhas

Antonio Lourenco

Jose Cotter

Affiliations

Soon will be listed here.

Abstract

Aim: To describe the proportion of patients with cirrhotic cardiomyopathy (CCM) evaluated by stress echocardiography and investigating its association with the severity of liver disease.

Methods: A cross-sectional study was conducted. Cirrhotic patients without risk factors for cardiovascular disease were included. Data regarding etiology and severity of liver disease (Child-Pugh score and model for end-stage liver disease), presence of ascites and gastroesophageal varices, pro-brain natriuretic peptide (pro-BNP) and corrected QT (QTc) interval were collected. Dobutamine stress echocardiography (conventional and tissue Doppler imaging) was performed. CCM was considered present when diastolic and/or systolic dysfunction was diagnosed at rest or after pharmacological stress. Therapy interfering with cardiovascular system was suspended 24 h before the examination.

Results: Twenty-six patients were analyzed, 17 (65.4%) Child-Pugh A, mean model for end-stage liver disease (MELD) score of 8.7. The global proportion of patients with CCM was 61.5%. At rest, only 2 (7.7%) patients had diastolic dysfunction and none of the patients had systolic dysfunction. Dobutamine stress echocardiography revealed the presence of diastolic dysfunction in more 6 (23.1%) patients and of systolic dysfunction in 10 (38.5%) patients. QTc interval prolongation was observed in 68.8% of the patients and increased pro-BNP levels in 31.2% of them. There was no association between the presence of CCM and liver impairment assessed by Child-Pugh score or MELD (P = 0.775, P = 0.532, respectively). Patients with QTc interval prolongation had a significant higher rate of gastroesophageal varices comparing with those without QTc interval prolongation (95.0% vs 50.0%, P = 0.028).

Conclusion: CCM is a frequent complication of cirrhosis that is independent of liver impairment. Stress evaluation should always be performed, otherwise it will remain an underdiagnosed condition.

Citing Articles

[Cirrhotic cardiomyopathy – Clinically fact or academic curiosity? Review. Part 2: ECG, functional tests, images, biomarkers, screening for coronary heart disease and differentianting diagnosis].

Ramos H, Altieri M Rev Fac Cien Med Univ Nac Cordoba. 2024; 81(2):432-452.

PMID: 38941220 PMC: 11370871. DOI: 10.31053/1853.0605.v81.n2.44419.

Markers of cardiac injury in patients with liver cirrhosis.

Simic S, Svagusa T, Grgurevic I, Mustapic S, Zarak M, Prkacin I Croat Med J. 2023; 64(5):362-373.

PMID: 37927191 PMC: 10668036.

Corrected QT interval in cirrhosis: A systematic review and meta-analysis.

Papadopoulos V, Mimidis K World J Hepatol. 2023; 15(9):1060-1083.

PMID: 37900213 PMC: 10600695. DOI: 10.4254/wjh.v15.i9.1060.

Syndecan-1: A Review on Its Role in Heart Failure and Chronic Liver Disease Patients' Assessment.

Miftode R, Serban I, Timpau A, Miftode I, Ion A, Buburuz A Cardiol Res Pract. 2019; 2019:4750580.

PMID: 31815014 PMC: 6878788. DOI: 10.1155/2019/4750580.

Prevalence and clinical presentation of cirrhotic cardiomyopathy: A single centre experience from southern India.

Bokarvadia R, Jain M, Kedarisetty C, Varghese J, Venkataraman J Indian J Gastroenterol. 2019; 38(2):150-157.

PMID: 31115783 DOI: 10.1007/s12664-019-00946-7.

References

Kazankov K, Holland-Fischer P, Andersen N, Torp P, Sloth E, Aagaard N . Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging. Liver Int. 2011; 31(4):534-40. DOI: 10.1111/j.1478-3231.2011.02468.x. View

Trevisani F, Merli M, Savelli F, Valeriano V, Zambruni A, Riggio O . QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt. J Hepatol. 2003; 38(4):461-7. DOI: 10.1016/s0168-8278(03)00057-6. View

Alexopoulou A, Papatheodoridis G, Pouriki S, Chrysohoou C, Raftopoulos L, Stefanadis C . Diastolic myocardial dysfunction does not affect survival in patients with cirrhosis. Transpl Int. 2012; 25(11):1174-81. DOI: 10.1111/j.1432-2277.2012.01547.x. View

Zambruni A, Trevisani F, Caraceni P, Bernardi M . Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol. 2006; 44(5):994-1002. DOI: 10.1016/j.jhep.2005.10.034. View

Zambruni A, Trevisani F, Di Micoli A, Savelli F, Berzigotti A, Bracci E . Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. J Hepatol. 2008; 48(3):415-21. DOI: 10.1016/j.jhep.2007.11.012. View

Nagueh S, Appleton C, Gillebert T, Marino P, Oh J, Smiseth O . Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009; 22(2):107-33. DOI: 10.1016/j.echo.2008.11.023. View

Krag A, Bendtsen F, Burroughs A, Moller S . The cardiorenal link in advanced cirrhosis. Med Hypotheses. 2012; 79(1):53-5. DOI: 10.1016/j.mehy.2012.03.032. View

Burgess M, Jenkins C, Sharman J, Marwick T . Diastolic stress echocardiography: hemodynamic validation and clinical significance of estimation of ventricular filling pressure with exercise. J Am Coll Cardiol. 2006; 47(9):1891-900. DOI: 10.1016/j.jacc.2006.02.042. View

Moller S, Henriksen J . Cirrhotic cardiomyopathy. J Hepatol. 2010; 53(1):179-90. DOI: 10.1016/j.jhep.2010.02.023. View

10.

Brutsaert D, Sys S, Gillebert T . Diastolic failure: pathophysiology and therapeutic implications. J Am Coll Cardiol. 1993; 22(1):318-25. DOI: 10.1016/0735-1097(93)90850-z. View

11.

Zardi E, Abbate A, Zardi D, Dobrina A, Margiotta D, Van Tassell B . Cirrhotic cardiomyopathy. J Am Coll Cardiol. 2010; 56(7):539-49. DOI: 10.1016/j.jacc.2009.12.075. View

12.

Lee S . Cardiac dysfunction in spontaneous bacterial peritonitis: a manifestation of cirrhotic cardiomyopathy?. Hepatology. 2003; 38(5):1089-91. DOI: 10.1053/jhep.2003.50489. View

13.

Torregrosa M, Aguade S, Dos L, Segura R, Gonzalez A, Evangelista A . Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol. 2005; 42(1):68-74. DOI: 10.1016/j.jhep.2004.09.008. View

14.

Lee R, Glenn T, Lee S . Cardiac dysfunction in cirrhosis. Best Pract Res Clin Gastroenterol. 2007; 21(1):125-40. DOI: 10.1016/j.bpg.2006.06.003. View

15.

Mahadevan G, Dwivedi G, Williams L, Steeds R, Frenneaux M . Epidemiology and diagnosis of heart failure with preserved left ventricular ejection fraction: rationale and design of the study. Eur J Heart Fail. 2011; 14(1):106-12. DOI: 10.1093/eurjhf/hfr153. View

16.

Baik S, Fouad T, Lee S . Cirrhotic cardiomyopathy. Orphanet J Rare Dis. 2007; 2:15. PMC: 1847677. DOI: 10.1186/1750-1172-2-15. View

17.

Moller S, Hove J, Dixen U, Bendtsen F . New insights into cirrhotic cardiomyopathy. Int J Cardiol. 2012; 167(4):1101-8. DOI: 10.1016/j.ijcard.2012.09.089. View

18.

Ruiz-Del-Arbol L, Urman J, Fernandez J, Gonzalez M, Navasa M, Monescillo A . Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 2003; 38(5):1210-8. DOI: 10.1053/jhep.2003.50447. View

19.

Enache I, Oswald-Mammosser M, Woehl-Jaegle M, Habersetzer F, Di Marco P, Charloux A . Cirrhotic cardiomyopathy and hepatopulmonary syndrome: prevalence and prognosis in a series of patients. Respir Med. 2013; 107(7):1030-6. DOI: 10.1016/j.rmed.2013.03.010. View

20.

Trevisani F, Di Micoli A, Zambruni A, Biselli M, Santi V, Erroi V . QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis. Liver Int. 2012; 32(10):1510-5. DOI: 10.1111/j.1478-3231.2012.02847.x. View